IMP
Process View
regulation of cellular amine metabolic process
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform amines.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of cellular amine metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| EGFR | epidermal growth factor receptor | 1.000 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 1.000 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 1.000 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 1.000 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 1.000 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 1.000 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 1.000 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 1.000 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 1.000 | ||
| APP | amyloid beta (A4) precursor protein | 1.000 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.999 | ||
| SYK | spleen tyrosine kinase | 0.999 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.999 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.999 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.998 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.998 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.998 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.997 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.997 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.997 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.996 | ||
| SMAD3 | SMAD family member 3 | 0.995 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.994 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.994 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.994 | ||
| CBX5 | chromobox homolog 5 | 0.994 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.993 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.993 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.992 | ||
| TP53 | tumor protein p53 | 0.992 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.992 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.990 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.990 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.989 | ||
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.988 | ||
| HDAC1 | histone deacetylase 1 | 0.988 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.988 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.988 | ||
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.988 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.988 | ||
| SMAD7 | SMAD family member 7 | 0.986 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.986 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.986 | ||
| PRKCA | protein kinase C, alpha | 0.983 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.983 | ||
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.981 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.980 | ||
| VEGFA | vascular endothelial growth factor A | 0.978 | ||
| ESR1 | estrogen receptor 1 | 0.978 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.978 | ||
| NCK1 | NCK adaptor protein 1 | 0.978 | ||
| AXL | AXL receptor tyrosine kinase | 0.977 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.976 | ||
| FHL2 | four and a half LIM domains 2 | 0.975 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.974 | ||
| SFN | stratifin | 0.972 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.970 | ||
| ENG | endoglin | 0.970 | ||
| PAX3 | paired box 3 | 0.968 | ||
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.967 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.965 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.964 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.964 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.961 | ||
| LAT | linker for activation of T cells | 0.960 | ||
| BCL2L1 | BCL2-like 1 | 0.960 | ||
| STK11 | serine/threonine kinase 11 | 0.958 | ||
| GHR | growth hormone receptor | 0.957 | ||
| CREBBP | CREB binding protein | 0.955 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.953 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.950 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.948 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.946 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.946 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.944 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.937 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.937 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.935 | ||
| SPRR2A | small proline-rich protein 2A | 0.933 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.933 | ||
| PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit | 0.928 | ||
| ARRB1 | arrestin, beta 1 | 0.925 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.917 | ||
| DLG1 | discs, large homolog 1 (Drosophila) | 0.915 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.914 | ||
| YAP1 | Yes-associated protein 1 | 0.911 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.910 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.907 | ||
| EPHA2 | EPH receptor A2 | 0.905 | ||
| MED28 | mediator complex subunit 28 | 0.904 | ||
| MPDZ | multiple PDZ domain protein | 0.901 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.901 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.900 | ||
| GH1 | growth hormone 1 | 0.900 | ||
| MAPT | microtubule-associated protein tau | 0.898 | ||
| RBBP4 | retinoblastoma binding protein 4 | 0.895 | ||
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.887 | ||
| RBBP5 | retinoblastoma binding protein 5 | 0.887 | ||
| NRIP1 | nuclear receptor interacting protein 1 | 0.886 | ||
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.884 | ||
| FLNA | filamin A, alpha | 0.882 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.881 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.878 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.878 | ||
| EP300 | E1A binding protein p300 | 0.878 | ||
| EIF3F | eukaryotic translation initiation factor 3, subunit F | 0.876 | ||
| PTEN | phosphatase and tensin homolog | 0.876 | ||
| ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0.875 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.874 | ||
| SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.873 | ||
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.872 | ||
| CD28 | CD28 molecule | 0.869 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.867 | ||
| HDAC7 | histone deacetylase 7 | 0.865 | ||
| SMAD2 | SMAD family member 2 | 0.858 | ||
| RB1 | retinoblastoma 1 | 0.856 | ||
| THBS1 | thrombospondin 1 | 0.855 | ||
| HCK | hemopoietic cell kinase | 0.854 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.846 | ||
| HDAC6 | histone deacetylase 6 | 0.844 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.836 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.834 | ||
| NRP1 | neuropilin 1 | 0.831 | ||
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.831 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.830 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.830 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.824 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.823 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.821 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.819 | ||
| BLNK | B-cell linker | 0.819 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.817 | ||
| GDF9 | growth differentiation factor 9 | 0.813 | ||
| EED | embryonic ectoderm development | 0.812 | ||
| IER3 | immediate early response 3 | 0.804 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.801 | ||
| AR | androgen receptor | 0.801 | ||
| IRS1 | insulin receptor substrate 1 | 0.799 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.795 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.795 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.794 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.791 | ||
| SCN5A | sodium channel, voltage-gated, type V, alpha subunit | 0.783 | ||
| CDK17 | cyclin-dependent kinase 17 | 0.783 | ||
| HDAC2 | histone deacetylase 2 | 0.777 | ||
| PRKAB2 | protein kinase, AMP-activated, beta 2 non-catalytic subunit | 0.776 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.774 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.774 | ||
| EPOR | erythropoietin receptor | 0.772 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.765 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.757 | ||
| MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.752 | ||
| SH2D1A | SH2 domain containing 1A | 0.749 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.748 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.740 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.729 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.725 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.725 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.719 | ||
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.715 | ||
| STC1 | stanniocalcin 1 | 0.713 | ||
| PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 0.713 | ||
| PRKCZ | protein kinase C, zeta | 0.710 | Human | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.707 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.704 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.701 | ||
| MSN | moesin | 0.698 | ||
| FN1 | fibronectin 1 | 0.695 | ||
| RUNX1 | runt-related transcription factor 1 | 0.695 | ||
| JUN | jun proto-oncogene | 0.694 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.693 | ||
| EZR | ezrin | 0.692 | ||
| ADNP | activity-dependent neuroprotector homeobox | 0.691 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.691 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.690 | ||
| FGF7 | fibroblast growth factor 7 | 0.689 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.684 | ||
| CBX1 | chromobox homolog 1 | 0.684 | ||
| LIFR | leukemia inhibitory factor receptor alpha | 0.679 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.677 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.675 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.675 | ||
| PDGFC | platelet derived growth factor C | 0.670 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.670 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.666 | ||
| EPHA7 | EPH receptor A7 | 0.665 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.659 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.656 | ||
| PROX1 | prospero homeobox 1 | 0.651 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.650 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.650 | ||
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.649 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.646 | ||
| AXIN1 | axin 1 | 0.644 | ||
| ABI2 | abl-interactor 2 | 0.643 | ||
| WDR5 | WD repeat domain 5 | 0.643 | ||
| NRP2 | neuropilin 2 | 0.637 | ||
| MEOX1 | mesenchyme homeobox 1 | 0.635 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.634 | ||
| VEGFC | vascular endothelial growth factor C | 0.634 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.630 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.630 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.627 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.626 | ||
| ASH2L | ash2 (absent, small, or homeotic)-like (Drosophila) | 0.625 | ||
| ARRB2 | arrestin, beta 2 | 0.623 | ||
| CHD8 | chromodomain helicase DNA binding protein 8 | 0.619 | ||
| MAPK12 | mitogen-activated protein kinase 12 | 0.619 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.617 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.616 | ||
| CUX1 | cut-like homeobox 1 | 0.614 | ||
| CTBP1 | C-terminal binding protein 1 | 0.611 | ||
| EPHA3 | EPH receptor A3 | 0.610 | ||
| FGA | fibrinogen alpha chain | 0.609 | ||
| CD9 | CD9 molecule | 0.609 | ||
| AMOT | angiomotin | 0.608 | ||
| CRMP1 | collapsin response mediator protein 1 | 0.607 | ||
| SOCS5 | suppressor of cytokine signaling 5 | 0.606 | ||
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.603 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.602 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.602 | ||
| TLN1 | talin 1 | 0.602 | ||
| PRKCE | protein kinase C, epsilon | 0.601 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.601 | ||
| IDE | insulin-degrading enzyme | 0.601 | ||
| CDAN1 | congenital dyserythropoietic anemia, type I | 0.600 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.599 | ||
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 0.596 | ||
| VIM | vimentin | 0.595 | ||
| LEO1 | Leo1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0.594 | ||
| SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0.594 | ||
| BAD | BCL2-associated agonist of cell death | 0.594 | ||
| SMAD6 | SMAD family member 6 | 0.593 | ||
| SNIP1 | Smad nuclear interacting protein 1 | 0.592 | ||
| FOXO1 | forkhead box O1 | 0.592 | ||
| DMD | dystrophin | 0.590 | ||
| TNF | tumor necrosis factor | 0.590 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.589 | ||
| SCHIP1 | schwannomin interacting protein 1 | 0.588 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.585 | ||
| EGR1 | early growth response 1 | 0.581 | ||
| SIRT1 | sirtuin 1 | 0.578 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.574 | ||
| FGF10 | fibroblast growth factor 10 | 0.569 | ||
| NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.569 | ||
| SLA | Src-like-adaptor | 0.569 | ||
| VAV2 | vav 2 guanine nucleotide exchange factor | 0.568 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.565 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.564 | ||
| PRNP | prion protein | 0.563 | ||
| SMAD1 | SMAD family member 1 | 0.561 | ||
| PLEKHA1 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 | 0.554 | ||
| IL6R | interleukin 6 receptor | 0.551 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.550 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.550 | ||
| IL22 | interleukin 22 | 0.546 | ||
| MYO10 | myosin X | 0.546 | ||
| HTT | huntingtin | 0.546 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.544 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.543 | ||
| CDC27 | cell division cycle 27 homolog (S. cerevisiae) | 0.540 | ||
| RTF1 | Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0.539 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.539 | ||
| TBX5 | T-box 5 | 0.537 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.535 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.534 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.533 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.532 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.531 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.530 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.529 | ||
| BID | BH3 interacting domain death agonist | 0.528 | ||
| CDC73 | cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0.523 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.518 | ||
| PRKCB | protein kinase C, beta | 0.515 | ||
| GAS7 | growth arrest-specific 7 | 0.508 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.505 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.504 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.503 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.503 | ||
| SH2D4A | SH2 domain containing 4A | 0.502 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.502 | ||
| CAV2 | caveolin 2 | 0.501 | ||
| APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 | 0.501 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.500 | ||
| PRRX1 | paired related homeobox 1 | 0.499 | ||
| ZFPM1 | zinc finger protein, multitype 1 | 0.499 | ||
| EFNA1 | ephrin-A1 | 0.498 | ||
| ZNF496 | zinc finger protein 496 | 0.498 | ||
| ANGPT2 | angiopoietin 2 | 0.498 | ||
| JAG1 | jagged 1 | 0.498 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.497 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.494 | ||
| JAM2 | junctional adhesion molecule 2 | 0.491 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.490 | ||
| FLNB | filamin B, beta | 0.489 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.489 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.488 | ||
| FZR1 | fizzy/cell division cycle 20 related 1 (Drosophila) | 0.487 | ||
| KLHL3 | kelch-like 3 (Drosophila) | 0.485 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.485 | ||
| BCR | breakpoint cluster region | 0.481 | ||
| NRG1 | neuregulin 1 | 0.481 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.481 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.479 | ||
| ANGPT1 | angiopoietin 1 | 0.479 | ||
| ANXA1 | annexin A1 | 0.479 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.479 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.478 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.477 | ||
| SUZ12 | suppressor of zeste 12 homolog (Drosophila) | 0.473 | ||
| FOXD3 | forkhead box D3 | 0.471 | ||
| RET | ret proto-oncogene | 0.471 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.471 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.469 | ||
| CASP8AP2 | caspase 8 associated protein 2 | 0.468 | ||
| LDLR | low density lipoprotein receptor | 0.468 | Mouse | |
| HIST2H3C | histone cluster 2, H3c | 0.467 | ||
| EFNA5 | ephrin-A5 | 0.467 | ||
| ITSN1 | intersectin 1 (SH3 domain protein) | 0.467 | ||
| PRR5 | proline rich 5 (renal) | 0.466 | ||
| MCAM | melanoma cell adhesion molecule | 0.466 | ||
| LMNA | lamin A/C | 0.464 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.464 | ||
| CXXC1 | CXXC finger protein 1 | 0.461 | ||
| DTNA | dystrobrevin, alpha | 0.460 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.459 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.459 | ||
| SSTR2 | somatostatin receptor 2 | 0.459 | ||
| DCN | decorin | 0.456 | ||
| TFF1 | trefoil factor 1 | 0.456 | ||
| INHBA | inhibin, beta A | 0.452 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.446 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.445 | ||
| MYST3 | MYST histone acetyltransferase (monocytic leukemia) 3 | 0.443 | ||
| TNC | tenascin C | 0.442 | ||
| WEE1 | WEE1 homolog (S. pombe) | 0.442 | ||
| NKX2-1 | NK2 homeobox 1 | 0.440 | ||
| IL4 | interleukin 4 | 0.440 | ||
| CCKBR | cholecystokinin B receptor | 0.440 | ||
| TANK | TRAF family member-associated NFKB activator | 0.439 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.439 | ||
| KNG1 | kininogen 1 | 0.438 | ||
| VASP | vasodilator-stimulated phosphoprotein | 0.436 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.436 | ||
| ITGA6 | integrin, alpha 6 | 0.435 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.435 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.434 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.434 | ||
| TGFA | transforming growth factor, alpha | 0.434 | ||
| RIN1 | Ras and Rab interactor 1 | 0.432 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.432 | ||
| OXSR1 | oxidative-stress responsive 1 | 0.432 | ||
| DCTN1 | dynactin 1 | 0.430 | ||
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.430 | ||
| BTRC | beta-transducin repeat containing | 0.430 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.429 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.426 | ||
| MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 0.426 | ||
| CDC14B | CDC14 cell division cycle 14 homolog B (S. cerevisiae) | 0.426 | ||
| SPRY2 | sprouty homolog 2 (Drosophila) | 0.426 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.425 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.424 | ||
| JAK3 | Janus kinase 3 | 0.423 | ||
| TP73 | tumor protein p73 | 0.423 | ||
| CALCA | calcitonin-related polypeptide alpha | 0.423 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.422 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.422 | ||
| BRCA1 | breast cancer 1, early onset | 0.422 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.421 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.419 | ||
| SELE | selectin E | 0.416 | ||
| MAPK10 | mitogen-activated protein kinase 10 | 0.416 | ||
| DLG5 | discs, large homolog 5 (Drosophila) | 0.414 | ||
| SOCS2 | suppressor of cytokine signaling 2 | 0.413 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.410 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.410 | ||
| YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.409 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.409 | ||
| IL9 | interleukin 9 | 0.409 | ||
| NGFR | nerve growth factor receptor | 0.407 | ||
| IRS4 | insulin receptor substrate 4 | 0.407 | ||
| CSHL1 | chorionic somatomammotropin hormone-like 1 | 0.406 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.402 | ||
| ARL2 | ADP-ribosylation factor-like 2 | 0.401 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.399 | ||
| SNX9 | sorting nexin 9 | 0.399 | ||
| IL11 | interleukin 11 | 0.398 | ||
| HIST1H3B | histone cluster 1, H3b | 0.397 | ||
| FZD5 | frizzled homolog 5 (Drosophila) | 0.397 | ||
| ADRA1D | adrenergic, alpha-1D-, receptor | 0.397 | ||
| THBS2 | thrombospondin 2 | 0.396 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.396 | ||
| PGF | placental growth factor | 0.395 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.394 | ||
| MAP1B | microtubule-associated protein 1B | 0.394 | ||
| PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 0.393 | ||
| E2F3 | E2F transcription factor 3 | 0.391 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.390 | ||
| STRADA | STE20-related kinase adaptor alpha | 0.390 | ||
| KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.390 | ||
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.390 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.386 | ||
| MAP1LC3B | microtubule-associated protein 1 light chain 3 beta | 0.385 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.385 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.384 | ||
| CTTN | cortactin | 0.383 | ||
| CBX3 | chromobox homolog 3 | 0.379 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.379 | ||
| ACTB | actin, beta | 0.378 | ||
| FHL3 | four and a half LIM domains 3 | 0.377 | ||
| NOS1 | nitric oxide synthase 1 (neuronal) | 0.376 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.375 | ||
| SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.374 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.374 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.374 | ||
| CSNK2B | casein kinase 2, beta polypeptide | 0.373 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.373 | ||
| TCEB1 | transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) | 0.372 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.371 | Human | |
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.371 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.370 | ||
| DGCR14 | DiGeorge syndrome critical region gene 14 | 0.370 | ||
| ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | 0.370 | ||
| GLP1R | glucagon-like peptide 1 receptor | 0.370 | ||
| IK | IK cytokine, down-regulator of HLA II | 0.365 | ||
| EFNB3 | ephrin-B3 | 0.364 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.363 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.362 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.360 | ||
| CFL1 | cofilin 1 (non-muscle) | 0.359 | ||
| POLR2A | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | 0.359 | ||
| KLF13 | Kruppel-like factor 13 | 0.358 | ||
| GH2 | growth hormone 2 | 0.357 | ||
| HAS2 | hyaluronan synthase 2 | 0.357 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.356 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.351 | ||
| FAM190B | family with sequence similarity 190, member B | 0.351 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.351 | ||
| EGR3 | early growth response 3 | 0.350 | ||
| PTPRF | protein tyrosine phosphatase, receptor type, F | 0.349 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.349 | ||
| SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.349 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.349 | ||
| ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 0.349 | ||
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.347 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.346 | ||
| SLC1A6 | solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | 0.345 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.345 | ||
| DARC | Duffy blood group, chemokine receptor | 0.344 | ||
| ATF3 | activating transcription factor 3 | 0.343 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.343 | ||
| FAT1 | FAT tumor suppressor homolog 1 (Drosophila) | 0.342 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.340 | ||
| NOS2 | nitric oxide synthase 2, inducible | 0.340 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.340 | ||
| LTK | leukocyte receptor tyrosine kinase | 0.340 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.339 | ||
| PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.339 | ||
| RBBP8 | retinoblastoma binding protein 8 | 0.338 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.338 | ||
| CLCN3 | chloride channel 3 | 0.337 | ||
| JAM3 | junctional adhesion molecule 3 | 0.335 | ||
| SHANK2 | SH3 and multiple ankyrin repeat domains 2 | 0.332 | ||
| PRDX1 | peroxiredoxin 1 | 0.332 | ||
| IRF4 | interferon regulatory factor 4 | 0.332 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.331 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.331 | ||
| AHR | aryl hydrocarbon receptor | 0.331 | ||
| IL10 | interleukin 10 | 0.329 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.328 | ||
| CCL14 | chemokine (C-C motif) ligand 14 | 0.326 | ||
| SH2D3A | SH2 domain containing 3A | 0.326 | ||
| CMIP | c-Maf-inducing protein | 0.325 | ||
| CSNK1G3 | casein kinase 1, gamma 3 | 0.324 | ||
| OSM | oncostatin M | 0.324 | ||
| TNS4 | tensin 4 | 0.324 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.322 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.322 | ||
| RELN | reelin | 0.320 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.319 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.319 | ||
| COASY | CoA synthase | 0.319 | ||
| RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | 0.319 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.318 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.317 | ||
| LRIF1 | ligand dependent nuclear receptor interacting factor 1 | 0.316 | ||
| OSMR | oncostatin M receptor | 0.315 | ||
| TBCD | tubulin folding cofactor D | 0.314 | ||
| GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 0.314 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.314 | ||
| CHAF1B | chromatin assembly factor 1, subunit B (p60) | 0.313 | ||
| ADAM10 | ADAM metallopeptidase domain 10 | 0.313 | ||
| TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.313 | ||
| CTBP2 | C-terminal binding protein 2 | 0.313 | ||
| POU2F2 | POU class 2 homeobox 2 | 0.313 | ||
| EMILIN1 | elastin microfibril interfacer 1 | 0.312 | ||
| TRAF4 | TNF receptor-associated factor 4 | 0.312 | ||
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.312 | ||
| EXT1 | exostosin 1 | 0.310 | ||
| INHBB | inhibin, beta B | 0.310 | ||
| FMNL1 | formin-like 1 | 0.307 | ||
| RUVBL1 | RuvB-like 1 (E. coli) | 0.307 | ||
| GATA2 | GATA binding protein 2 | 0.306 | Human | |
| CH25H | cholesterol 25-hydroxylase | 0.305 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.305 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.305 | ||
| CALR | calreticulin | 0.304 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.303 | ||
| SLC6A2 | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 0.303 | ||
| IFNB1 | interferon, beta 1, fibroblast | 0.303 | ||
| LIMK1 | LIM domain kinase 1 | 0.302 | ||
| ERCC8 | excision repair cross-complementing rodent repair deficiency, complementation group 8 | 0.302 | ||
| STK10 | serine/threonine kinase 10 | 0.301 | ||
| MYOD1 | myogenic differentiation 1 | 0.301 | ||
| MCM7 | minichromosome maintenance complex component 7 | 0.300 | ||
| LAMC2 | laminin, gamma 2 | 0.300 | ||
| KITLG | KIT ligand | 0.300 | ||
| GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 0.300 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.299 | ||
| VAC14 | Vac14 homolog (S. cerevisiae) | 0.299 | ||
| LRP5 | low density lipoprotein receptor-related protein 5 | 0.299 | ||
| IL13 | interleukin 13 | 0.298 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.297 | ||
| TESK1 | testis-specific kinase 1 | 0.296 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.295 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.295 | ||
| F2RL3 | coagulation factor II (thrombin) receptor-like 3 | 0.295 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.294 | ||
| PLAU | plasminogen activator, urokinase | 0.294 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.293 | ||
| GFAP | glial fibrillary acidic protein | 0.292 | ||
| KCNMA1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | 0.292 | ||
| AMOTL2 | angiomotin like 2 | 0.292 | ||
| IL7R | interleukin 7 receptor | 0.291 | ||
| RARB | retinoic acid receptor, beta | 0.290 | ||
| GHRHR | growth hormone releasing hormone receptor | 0.289 | ||
| MBNL1 | muscleblind-like (Drosophila) | 0.289 | ||
| RBBP7 | retinoblastoma binding protein 7 | 0.288 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.288 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.288 | ||
| GREM1 | gremlin 1 | 0.287 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.287 | ||
| WDR61 | WD repeat domain 61 | 0.287 | ||
| DRD1 | dopamine receptor D1 | 0.287 | Mouse | |
| FGF18 | fibroblast growth factor 18 | 0.287 | ||
| PPP1R2 | protein phosphatase 1, regulatory (inhibitor) subunit 2 | 0.286 | ||
| CLU | clusterin | 0.286 | ||
| CD81 | CD81 molecule | 0.285 | ||
| STAB1 | stabilin 1 | 0.285 | ||
| KCNJ4 | potassium inwardly-rectifying channel, subfamily J, member 4 | 0.283 | ||
| SPRY1 | sprouty homolog 1, antagonist of FGF signaling (Drosophila) | 0.282 | ||
| CD63 | CD63 molecule | 0.282 | ||
| HIC1 | hypermethylated in cancer 1 | 0.279 | ||
| CALCR | calcitonin receptor | 0.279 | ||
| XAB2 | XPA binding protein 2 | 0.279 | ||
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.279 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.279 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.279 | ||
| ADRB3 | adrenergic, beta-3-, receptor | 0.278 | ||
| BDNF | brain-derived neurotrophic factor | 0.278 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.277 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.277 | ||
| SMARCA1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 | 0.277 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.277 | ||
| CD2 | CD2 molecule | 0.277 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.277 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.276 | ||
| RNF19A | ring finger protein 19A | 0.276 | ||
| DAB1 | disabled homolog 1 (Drosophila) | 0.276 | ||
| SNCG | synuclein, gamma (breast cancer-specific protein 1) | 0.275 | ||
| AKAP2 | A kinase (PRKA) anchor protein 2 | 0.275 | ||
| PDE4D | phosphodiesterase 4D, cAMP-specific | 0.274 | ||
| F2RL1 | coagulation factor II (thrombin) receptor-like 1 | 0.273 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.273 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.272 | ||
| NOS1AP | nitric oxide synthase 1 (neuronal) adaptor protein | 0.272 | ||
| PCDH7 | protocadherin 7 | 0.272 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.271 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.270 | ||
| ALK | anaplastic lymphoma receptor tyrosine kinase | 0.268 | ||
| EEF2K | eukaryotic elongation factor-2 kinase | 0.268 | ||
| LRCH1 | leucine-rich repeats and calponin homology (CH) domain containing 1 | 0.268 | ||
| MAP3K10 | mitogen-activated protein kinase kinase kinase 10 | 0.268 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.268 | ||
| TRIP13 | thyroid hormone receptor interactor 13 | 0.267 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.267 | ||
| SYN1 | synapsin I | 0.266 | ||
| AHNAK | AHNAK nucleoprotein | 0.266 | ||
| PPHLN1 | periphilin 1 | 0.266 | ||
| REV3L | REV3-like, catalytic subunit of DNA polymerase zeta (yeast) | 0.265 | ||
| CD84 | CD84 molecule | 0.265 | ||
| PDE10A | phosphodiesterase 10A | 0.265 | ||
| IL1A | interleukin 1, alpha | 0.265 | ||
| COL14A1 | collagen, type XIV, alpha 1 | 0.264 | ||
| RGS4 | regulator of G-protein signaling 4 | 0.264 | ||
| ITGB8 | integrin, beta 8 | 0.263 | ||
| DEAF1 | deformed epidermal autoregulatory factor 1 (Drosophila) | 0.263 | ||
| MMP19 | matrix metallopeptidase 19 | 0.263 | ||
| DKK3 | dickkopf homolog 3 (Xenopus laevis) | 0.262 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.262 | ||
| PIK3CD | phosphoinositide-3-kinase, catalytic, delta polypeptide | 0.262 | ||
| PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | 0.262 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.262 | ||
| NCL | nucleolin | 0.261 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.261 | ||
| CSH1 | chorionic somatomammotropin hormone 1 (placental lactogen) | 0.261 | ||
| SH3D19 | SH3 domain containing 19 | 0.261 | ||
| FGFR4 | fibroblast growth factor receptor 4 | 0.261 | ||
| BMP4 | bone morphogenetic protein 4 | 0.260 | ||
| STC2 | stanniocalcin 2 | 0.259 | ||
| SSTR3 | somatostatin receptor 3 | 0.259 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.258 | ||
| DAPK1 | death-associated protein kinase 1 | 0.258 | ||
| MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 | 0.258 | ||
| CD2AP | CD2-associated protein | 0.258 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.258 | ||
| CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) | 0.258 | ||
| FGF6 | fibroblast growth factor 6 | 0.257 | ||
| USP5 | ubiquitin specific peptidase 5 (isopeptidase T) | 0.257 | ||
| UBC | ubiquitin C | 0.256 | ||
| NPY2R | neuropeptide Y receptor Y2 | 0.255 | ||
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.255 | ||
| LPAR1 | lysophosphatidic acid receptor 1 | 0.255 | ||
| KDM6B | lysine (K)-specific demethylase 6B | 0.255 | ||
| CRIPAK | cysteine-rich PAK1 inhibitor | 0.255 | ||
| ARRDC3 | arrestin domain containing 3 | 0.254 | ||
| JUB | jub, ajuba homolog (Xenopus laevis) | 0.254 | ||
| RUNX2 | runt-related transcription factor 2 | 0.254 | ||
| CDK11B | cyclin-dependent kinase 11B | 0.253 | ||
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.253 | ||
| F11R | F11 receptor | 0.253 | ||
| ARL3 | ADP-ribosylation factor-like 3 | 0.253 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.253 | ||
| SOX13 | SRY (sex determining region Y)-box 13 | 0.253 | ||
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.252 | ||
| CYTH1 | cytohesin 1 | 0.252 | ||
| CALD1 | caldesmon 1 | 0.252 | ||
| MYST2 | MYST histone acetyltransferase 2 | 0.252 | ||
| CLEC4M | C-type lectin domain family 4, member M | 0.251 | ||
| DCBLD2 | discoidin, CUB and LCCL domain containing 2 | 0.251 | ||
| RANBP2 | RAN binding protein 2 | 0.251 | ||
| DDX4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 0.251 | ||
| ACVR1B | activin A receptor, type IB | 0.250 | ||
| SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.250 | ||
| SH2D2A | SH2 domain containing 2A | 0.250 | ||
| PNRC2 | proline-rich nuclear receptor coactivator 2 | 0.250 | ||
| TRIO | triple functional domain (PTPRF interacting) | 0.249 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.249 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.249 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.249 | ||
| E2F2 | E2F transcription factor 2 | 0.249 | ||
| PRKCQ | protein kinase C, theta | 0.248 | Human | |
| NOTCH4 | notch 4 | 0.248 | ||
| EIF6 | eukaryotic translation initiation factor 6 | 0.247 | ||
| ITGB4 | integrin, beta 4 | 0.247 | ||
| GDNF | glial cell derived neurotrophic factor | 0.247 | ||
| MARCKSL1 | MARCKS-like 1 | 0.247 | ||
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0.246 | ||
| ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.246 | ||
| PAX7 | paired box 7 | 0.245 | ||
| SMAD5 | SMAD family member 5 | 0.245 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.245 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.245 | ||
| NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 0.244 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.244 | ||
| PYY | peptide YY | 0.244 | ||
| FOXF1 | forkhead box F1 | 0.244 | ||
| SPP1 | secreted phosphoprotein 1 | 0.244 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.243 | ||
| TCEAL5 | transcription elongation factor A (SII)-like 5 | 0.243 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.242 | ||
| CD4 | CD4 molecule | 0.242 | ||
| BMI1 | BMI1 polycomb ring finger oncogene | 0.242 | ||
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.242 | ||
| SH3GL3 | SH3-domain GRB2-like 3 | 0.242 | ||
| KCNQ1 | potassium voltage-gated channel, KQT-like subfamily, member 1 | 0.242 | ||
| IRF8 | interferon regulatory factor 8 | 0.241 | ||
| FBXO11 | F-box protein 11 | 0.241 | ||
| PTHLH | parathyroid hormone-like hormone | 0.241 | ||
| EPS15 | epidermal growth factor receptor pathway substrate 15 | 0.241 | ||
| STK38L | serine/threonine kinase 38 like | 0.241 | ||
| EPHB2 | EPH receptor B2 | 0.240 | ||
| GRM1 | glutamate receptor, metabotropic 1 | 0.240 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.240 | ||
| ACTN1 | actinin, alpha 1 | 0.239 | ||
| OPRM1 | opioid receptor, mu 1 | 0.239 | ||
| MOBKL1A | MOB1, Mps One Binder kinase activator-like 1A (yeast) | 0.239 | ||
| CRP | C-reactive protein, pentraxin-related | 0.239 | ||
| STK38 | serine/threonine kinase 38 | 0.239 | ||
| ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.238 | ||
| PURA | purine-rich element binding protein A | 0.237 | ||
| PLXDC1 | plexin domain containing 1 | 0.237 | ||
| TSPAN4 | tetraspanin 4 | 0.237 | ||
| CHUK | conserved helix-loop-helix ubiquitous kinase | 0.237 | ||
| PREX1 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 | 0.237 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.237 | ||
| SELPLG | selectin P ligand | 0.236 | ||
| HR | hairless homolog (mouse) | 0.236 | ||
| FST | follistatin | 0.236 | ||
| PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 0.235 | ||
| WNT3A | wingless-type MMTV integration site family, member 3A | 0.234 | ||
| TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.234 | ||
| DLGAP2 | discs, large (Drosophila) homolog-associated protein 2 | 0.234 | ||
| BAZ2B | bromodomain adjacent to zinc finger domain, 2B | 0.234 | ||
| SMS | spermine synthase | 0.234 | ||
| DOT1L | DOT1-like, histone H3 methyltransferase (S. cerevisiae) | 0.234 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.233 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.233 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.233 | ||
| YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.233 | ||
| PAF1 | Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae) | 0.233 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.233 | ||
| SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 | 0.233 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.232 | ||
| EPHB3 | EPH receptor B3 | 0.232 | ||
| ZEB2 | zinc finger E-box binding homeobox 2 | 0.232 | ||
| IFNG | interferon, gamma | 0.232 | ||
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.231 | ||
| CAPRIN2 | caprin family member 2 | 0.231 | ||
| TG | thyroglobulin | 0.231 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.231 | ||
| TCIRG1 | T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 | 0.230 | ||
| CSH2 | chorionic somatomammotropin hormone 2 | 0.230 | ||
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.230 | ||
| NFIB | nuclear factor I/B | 0.229 | ||
| APBA1 | amyloid beta (A4) precursor protein-binding, family A, member 1 | 0.229 | ||
| MAP2K2 | mitogen-activated protein kinase kinase 2 | 0.229 | ||
| MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | 0.229 | ||
| SPTAN1 | spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) | 0.229 | ||
| FHL1 | four and a half LIM domains 1 | 0.228 | ||
| AVPR1B | arginine vasopressin receptor 1B | 0.228 | ||
| TLK1 | tousled-like kinase 1 | 0.227 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.227 | ||
| CPD | carboxypeptidase D | 0.227 | ||
| DPT | dermatopontin | 0.227 | ||
| ZEB1 | zinc finger E-box binding homeobox 1 | 0.226 | ||
| VAV3 | vav 3 guanine nucleotide exchange factor | 0.226 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.226 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.225 | ||
| ITK | IL2-inducible T-cell kinase | 0.224 | ||
| SLIT3 | slit homolog 3 (Drosophila) | 0.224 | ||
| SLC6A1 | solute carrier family 6 (neurotransmitter transporter, GABA), member 1 | 0.224 | ||
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.224 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.224 | ||
| EFNB2 | ephrin-B2 | 0.224 | ||
| GATA5 | GATA binding protein 5 | 0.224 | Human | |
| GATA4 | GATA binding protein 4 | 0.223 | Human | |
| GRIK1 | glutamate receptor, ionotropic, kainate 1 | 0.223 | ||
| LPHN3 | latrophilin 3 | 0.223 |